12.1
위장관(GI) 진단 검사는 암을 포함한 다양한 질병을 확인, 배제, 진단 또는 병기화하는 데 핵심적입니다. 진단 후 환자와 논의할 시간을 할당하고 정보 리소스를 제공하는 것이 중요합니다. GI관에 대한 진단 평가는 종종 내시경실이나 GI 실험실과 같은 외래 환경에서 이…
위장 검사에는 혈청, 호흡 및 대변 검사가 포함됩니다.
첫째, 간 기능 검사와 같은 혈청 연구는 간 질환을 식별하는 데 도움이 됩니다. 아밀라아제와 리파아제 수치가 높아지면 췌장 염증을 나타내는 경우가 많습니다. 종합적인 대사 패널은 신장 및 간 기능, 전해질 균형 및 혈당 수치를 평가합니다.
또한 암배아 항원과 같은 종양 마커는 결장직장암을 검출하는 반면 암 항원 19-9는 췌장암을 검출합니다.
다음으로, 수소 호흡 검사와 같은 호흡 검사는 특히 유당 불내증과 소장 세균 과다 증식에서 탄수화물 흡수 장애를 식별합니다.
요소 호흡 검사는 소화성 궤양 질환과 관련된 박테리아인 H.pylori를 검출합니다.
마지막으로, 대변 검사는 대변의 일관성, 색깔, 고름, 점액, 기생충 및 잠혈을 검사하여 진단 정보를 제공합니다.
대변 배양은 살모넬라균과 같은 박테리아를 식별하여 설사와 식중독을 진단하는 데 도움이 됩니다.
마지막으로, 과이악 기반 분변 잠혈 검사와 분변 면역화학 검사는 대장암 검진의 핵심입니다.
View the full transcript and gain access to JoVE Core videos
Q1: What do liver function tests reveal about gastrointestinal health?
Liver function tests assess liver health by measuring liver enzymes, proteins, and bilirubin levels in the blood. Abnormal results may indicate liver disorders such as hepatitis or cirrhosis. These serum studies help identify hepatic dysfunction and guide treatment decisions for patients with suspected liver disease.
Q2: How do elevated amylase and lipase levels indicate pancreatic problems?
Elevated amylase and lipase levels often indicate pancreatic inflammation, particularly pancreatitis. These enzymes are released into the bloodstream when pancreatic tissue is damaged or inflamed. While increased levels suggest pancreatitis, they may also rise in other conditions, making clinical correlation essential for accurate diagnosis.
Q3: What is the difference between the hydrogen breath test and urea breath test?
The hydrogen breath test identifies carbohydrate malabsorption, such as lactose intolerance and small intestinal bacterial overgrowth, by measuring hydrogen levels in exhaled breath. The urea breath test detects Helicobacter pylori, a bacterium associated with peptic ulcer disease. Both are non-invasive diagnostic methods targeting different gastrointestinal conditions.
Q4: How do tumor markers like CEA and CA 19-9 help detect gastrointestinal cancers?
Carcinoembryonic antigen detects colorectal carcinoma, while cancer antigen 19-9 detects pancreatic cancer. Elevated levels may suggest the presence of cancer, though they can also occur in other conditions. These tumor markers are valuable screening and monitoring tools but are not diagnostic on their own and must be used alongside imaging studies and clinical evaluation.
Q5: What information does stool examination provide about gastrointestinal disorders?
Stool tests examine consistency, color, pus, mucus, parasites, and occult blood to diagnose gastrointestinal conditions. Stool culture identifies bacteria such as Salmonella, aiding in diagnosing diarrhea and food poisoning. These observations can indicate bleeding, infections, infestations, or malabsorption syndromes affecting the digestive system.
Q6: Why are fecal occult blood tests important for colorectal cancer screening?
Guaiac-based fecal occult blood testing and fecal immunochemical tests are key screening tools for colorectal cancer. Hidden blood in stool is a crucial marker for conditions like colorectal cancer. The fecal immunochemical test offers higher specificity for human hemoglobin and is preferred for colorectal cancer screening over guaiac-based tests.
Q7: What does the comprehensive metabolic panel evaluate in gastrointestinal assessment?
The comprehensive metabolic panel evaluates kidney and liver function, electrolyte balance, and blood sugar levels. This broad overview of body chemistry is essential for diagnosing metabolic disorders and understanding overall organ function. It provides critical information for assessing patients with gastrointestinal complaints and systemic involvement.